277 revision surgeries have been performed due to faulty J&J hip implants: Minister

The Health Ministry has also requested all the states/UTs to form state-level committees to examine the affected patients within their jurisdiction so that the process is less arduous for them.

Published: 13th December 2018 08:26 AM  |   Last Updated: 13th December 2018 08:26 AM   |  A+A-

hospital, medical, doctor, bill, medicine, treatment

Image used for representational purpose only.

By PTI

NEW DELHI: A total of 277 revision surgeries have been performed due to the faulty ASR hip implants manufactured by DePuy International Ltd, a subsidiary of Johnson and Johnson, Minister of State for Health Ashwini Choubey told the Rajya Sabha Tuesday.

The minister was replying to a question on whether faulty hip implants had resulted in deaths and disability of several patients.

"As per the information available with the Central Drugs Standard Control Organisation (CDSCO), 277 revision surgeries were undertaken because of disability due to faulty Articular Surface Replacement (ASR) hip implants manufactured by M/s DePuy International Limited, UK, (now M/s Johnson & Johnson Pvt Ltd)," Choubey said in his reply.

He said the government had set up a panel to examine issues relating to the faulty hip implants.

The committee, after a detailed examination of the issue, submitted its report to the government, which accepted the recommendations with some modifications.

Based on the accepted recommendations, the government constituted a central expert committee under the chairmanship of Sports Injury Centre Director RK Arya inter-alia to determine the quantum of compensation, Choubey said.

The Health Ministry has also requested all the states/UTs to form state-level committees to examine the affected patients within their jurisdiction so that the process is less arduous for them.

"A formula for determining compensation for the affected patients has also been formulated and placed in public domain. The affected patients can approach either the central expert committee or state-level committee as per their convenience," Choubey said.

Responding to a question on whether the government was aware that the hip implants of the same manufacturer were recalled in the United States due to its faulty equipments and if so, the reasons it was allowed to market the product in India, Choubey said the product was recalled in the US in August 2010.

In India, the firm recalled it on August 24, 2010 and Central Drugs Standard Control Organisation (CDSCO) acknowledged their recall and no further import of the product was allowed, he said.

Stay up to date on all the latest Nation news with The New Indian Express App. Download now
(Get the news that matters from New Indian Express on WhatsApp. Click this link and hit 'Click to Subscribe'. Follow the instructions after that.)

Comments

Disclaimer : We respect your thoughts and views! But we need to be judicious while moderating your comments. All the comments will be moderated by the newindianexpress.com editorial. Abstain from posting comments that are obscene, defamatory or inflammatory, and do not indulge in personal attacks. Try to avoid outside hyperlinks inside the comment. Help us delete comments that do not follow these guidelines.

The views expressed in comments published on newindianexpress.com are those of the comment writers alone. They do not represent the views or opinions of newindianexpress.com or its staff, nor do they represent the views or opinions of The New Indian Express Group, or any entity of, or affiliated with, The New Indian Express Group. newindianexpress.com reserves the right to take any or all comments down at any time.

flipboard facebook twitter whatsapp